Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://novomedix.com/sitemap_index.xml # --------------------------- # END YOAST |
Title | Novomedix | Transforming the Treatment of Cancer and |
Description | Search for: About Us Our Approach Pipeline Programs News and Publications Careers Contact Search for: About Us Our Approach Pipeline Programs News and Pub |
Keywords | N/A |
WebSite | novomedix.com |
Host IP | 35.208.88.70 |
Location | United States |
Site | Rank |
US$1,144,645
Last updated: 2023-04-28 07:36:32
novomedix.com has Semrush global rank of 9,246,807. novomedix.com has an estimated worth of US$ 1,144,645, based on its estimated Ads revenue. novomedix.com receives approximately 132,075 unique visitors each day. Its web server is located in United States, with IP address 35.208.88.70. According to SiteAdvisor, novomedix.com is safe to visit. |
Purchase/Sale Value | US$1,144,645 |
Daily Ads Revenue | US$1,057 |
Monthly Ads Revenue | US$31,698 |
Yearly Ads Revenue | US$380,375 |
Daily Unique Visitors | 8,805 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
novomedix.com. | A | 14400 | IP: 35.208.88.70 |
novomedix.com. | NS | 86400 | NS Record: ns1.siteground.net. |
novomedix.com. | NS | 86400 | NS Record: ns2.siteground.net. |
novomedix.com. | MX | 3600 | MX Record: 30 mx30.mailspamprotection.com. |
novomedix.com. | MX | 3600 | MX Record: 20 mx20.mailspamprotection.com. |
novomedix.com. | MX | 3600 | MX Record: 10 mx10.mailspamprotection.com. |
novomedix.com. | TXT | 14400 | TXT Record: v=spf1 +a +mx +ip4:35.208.89.39 include:_spf.mailspamprotection.com ~all |
Search for: About Us Our Approach Pipeline Programs News and Publications Careers Contact Search for: About Us Our Approach Pipeline Programs News and Publications Careers Contact About Us Our Approach Pipeline Programs News and Publications Careers Contact Novomedix Araceli Richardson 2022-09-24T08:48:43-07:00 Transforming the Treatment of Cancer and Fibrosis We are proven drug developers We are a biotechnology company developing novel small molecule multi-pathway modulators for the treatment of cancer, fibrosis, and inflammatory diseases. We have amassed a significant wealth of expertise in our therapeutic areas of interest, with decades of drug development experience. Learn More Recent News and Publications NovoMedix Presents New Preclinical Data on NMX2 at the 2022 American Heart Association (AHA) Scientific Sessions Meeting SAN DIEGO, Nov. 7, 2022 /PRNewswire/ -- NovoMedix, LLC ("NovoMedix"), a biotechnology company developing novel, multi-pathway modulators for ... Read More AHA |
HTTP/1.1 200 OK Server: nginx Date: Thu, 21 Oct 2021 10:32:41 GMT Content-Type: text/html Content-Length: 8047 Connection: keep-alive Vary: Accept-Encoding Last-Modified: Fri, 12 Mar 2021 21:22:03 GMT ETag: "1f6f-5bd5d7dca32b0" Accept-Ranges: bytes X-Httpd: 1 Host-Header: 8441280b0c35cbc1147f8ba998a563a7 X-Proxy-Cache-Info: DT:1 |
Domain Name: NOVOMEDIX.COM Registry Domain ID: 72324958_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.tucows.com Registrar URL: http://www.tucows.com Updated Date: 2021-05-17T04:20:10Z Creation Date: 2001-06-11T04:55:28Z Registry Expiry Date: 2022-06-11T04:55:28Z Registrar: Tucows Domains Inc. Registrar IANA ID: 69 Domain Status: ok https://icann.org/epp#ok Name Server: NS1.M41.SITEGROUND.BIZ Name Server: NS2.M41.SITEGROUND.BIZ DNSSEC: unsigned >>> Last update of whois database: 2021-09-10T04:24:41Z <<< |